FEELM Unveils New Disposable Solution at UK's VApril Event

Apr.24.2023
FEELM Unveils New Disposable Solution at UK's VApril Event
FEELM, a tech brand under SMOORE, presents its innovative FEELM Max disposable solution at VApril, a UK e-vapor event.

Recently, FEELM, a technology brand under SMOORE, showcased its upgraded FEELM Max ceramic core disposable solution at VApril, a UK-based event focused on e-vapor products. The event, organized by the UK Vaping Industry Association (UKVIA), aims to assist more users in transitioning to e-vapor and has been running for six consecutive years.

 

During VApril, FEELM partnered with multiple e-vapor product stores in central London to distribute free samples of the FEELM Max disposable solution to consumers, allowing them to experience a high-quality e-vapor experience. Last month, John Dunne, the UKVA's Director-General, expressed the government's concern for the regulated development of the disposable industry, calling for full compliance in order to promote healthy growth in the European e-vapor sector.

 

FEELM Unveils New Disposable Solution at UK's VApril Event
Customer trying FEELM product | Smoore

 

After being distributed, the FEELM Max solution attracted the attention of both British consumers and store owners, with many praising the ceramic core disposable solution as a competitive and optimal choice under regulatory conditions. Users noted the high-quality feel and transparency of the oil chamber, as well as the impressive performance of the ceramic core. The upgraded FEELM Max ceramic core disposable solution is set to launch in Birmingham, UK, on May 13th, offering a premium disposable experience for global users.

 

Previously in this March, SMOORE launched its newly developed power solution PowerAlpha designed for disposables at the Las Vegas APE expo.

 

On April. 26 at GMT 11 AM, UKVIA will join 2FIRSTS live stream to interpret the UK government's recent movements. Please stay tuned.
 

FEELM Unveils New Disposable Solution at UK's VApril Event

 

*The content of this article is written after the extraction, compilation and integration of multiple information for exchange and learning purposes. The copyright of the summary information still belongs to the original article and its author. If any infringement is found, please contact us to delete it. 

JT’s Ploom Volumes Rise 43.5% as Cigarettes Anchor Its Transition
JT’s Ploom Volumes Rise 43.5% as Cigarettes Anchor Its Transition
JT’s Ploom heated-tobacco volumes rose 43.5% in the first half of 2026, while combustibles still represented about 97% of its tobacco volume and remained the main earnings base. In Japan, reduced-risk products now account for 48.7% of industry shipments, shifting competition from category adoption towards brand share, pricing and consumer retention. JT’s results offer a revealing case of a traditional tobacco company pursuing a prolonged, dual-track transformation.
JTI
Jul.30
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia is strengthening controls on nicotine pouches under its existing therapeutic goods regulatory framework. According to the Therapeutic Goods Administration (TGA), nicotine pouch products must meet regulatory requirements, and unapproved products cannot be legally imported. The move follows Australia’s broader approach of maintaining strict oversight of nicotine products, including nicotine-containing vapes. As nicotine pouches expand globally, Australia’s regulatory approach highlights growing differences in how countries manage emerging smoke-free nicotine products.
Regulations
Jul.27
Global Tobacco Control Faces Regional Adaptation Test as Nicotine Markets Evolve, Asian Specialist Says
Global Tobacco Control Faces Regional Adaptation Test as Nicotine Markets Evolve, Asian Specialist Says
As e-cigarettes, heated tobacco products and nicotine pouches expand across global markets, a central question is gaining urgency: can tobacco control rely on a universal policy model? In an interview with 2Firsts, Asian public health and addiction medicine specialist Dr. Rashidi Mohamed bin Pakri Mohamed says Western experience remains relevant, but policies must be adapted to local culture, healthcare systems, enforcement capacity, illicit markets and clinical evidence.
Jul.08
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
The U.S. Food and Drug Administration (FDA) said its youth e-cigarette prevention campaign, “The Real Cost,” prevented about 444,000 U.S. youth from starting e-cigarette use between 2023 and 2024 and blocked more than $42 million in unauthorized e-cigarette sales that would have been used by youth.
Market
Jun.25
FDA Sued Over Allowing Some Unauthorized Vapes and Nicotine Pouches to Stay on Market
FDA Sued Over Allowing Some Unauthorized Vapes and Nicotine Pouches to Stay on Market
Public health groups, pediatricians and parents sued the U.S. Food and Drug Administration on July 14, 2026, challenging a May enforcement guidance that they say allows unauthorized e-cigarettes and nicotine pouches to remain on the market while applications are under review.
Jul.15
Product | APUS Launches Chloe 50K, Bringing Purse-Inspired Design to the U.S. High-Puff Disposable Market
Product | APUS Launches Chloe 50K, Bringing Purse-Inspired Design to the U.S. High-Puff Disposable Market
APUS has introduced the Chloe 50K disposable vape, which has appeared across U.S.-facing online retail channels including Element Vape and Vapesourcing. The device combines a purse-inspired body and chain attachment with a 20ml e-liquid capacity, 1,250mAh rechargeable battery, dual mesh coil, and battery and e-liquid indicators. It is rated for up to 50,000 puffs. The product does not appear on the FDA’s current list of authorized e-cigarettes, and U.S. retail availability does not indicate FDA marketing authorization.
Jul.15